The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
According to Parks Associates, EV owners are twice as likely to also own smart home equipment, meaning playing into EVs in the home could potentially help integrators garner higher sales. If you t...
According to recent Parks Associates data, US households spend an average of $116 a month on home internet, which is a sizable chunk of change. Whether you use it for remote work, streaming your favor...
Investors are still apparently eager for more as the company continues to pivot toward a services-based model from its current focus making boxes for streaming television—a focus that, so far, has bee...
William Blair upgraded Netflix, Inc. (NASDAQ:NFLX) to Outperform in August 2016 and believes there continues to be upside potential for the streaming video leader. Through William Blair's research, it...
